ImmunityBio director Barry Simon sells $268,760 in stock
Covered in this story
What has happened since
- Immunitybio Inc is up 0.6% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $IBRX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Immunitybio Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.